Phenotypes of Psoriasis in Patients in Need of Systemic Treatment, and Correlation with Personal Habits, Treatment History and Comorbidities: A Cross-sectional Latent Class Analysis of Data from the Italian PsoReal Registry

Phenotypes of Psoriasis in Patients in Need of Systemic Treatment, and Correlation with Personal Habits, Treatment History and Comorbidities: A Cross-sectional Latent Class Analysis of Data from the Italian PsoReal Registry

Abstract is missing (Short communication)

Bibliographic Details
Main Authors:	Simone Cazzaniga, Kristine Heidemeyer, Luigi Naldi
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2023-04-01
Series:	Acta Dermato-Venereologica
Subjects:	psoriasis latent class analysis phenotypes comorbidities disease characterization
Online Access:	https://medicaljournalssweden.se/actadv/article/view/5331

Similar Items

Psoriasis comorbidity: prevalence, diagnosis and treatment
by: SHI Yuling, CHEN Wenjuan
Published: (2023-06-01)

Comorbidities and Medication Use in Finnish Patients with Psoriasis: A Population-Based Registry Study
by: Aino Vesikansa, et al.
Published: (2023-03-01)

Comorbidity in Adult Psoriasis: Considerations for the Clinician
by: Daugaard C, et al.
Published: (2022-06-01)

Immunity: Psoriasis comorbid with atherosclerosis
by: Chunping Liu, et al.
Published: (2022-12-01)

Comorbidities in pediatric psoriasis patients: A retrospective single-center study
by: Gülistan Maçin, et al.
Published: (2022-09-01)

Multimorbidity of Psoriasis: A Large-Scale Population Study of Its Associated Comorbidities
by: Manuel Almenara-Blasco, et al.
Published: (2024-01-01)

Psoriasis comorbidities: complications and benefits of immunobiological treatment
by: André Vicente Esteves de Carvalho, et al.
Published: (2016-12-01)

Impact of Comorbidities of Patients with Psoriasis on Phototherapy Responses
by: Belén Fatás-Lalana, et al.
Published: (2022-08-01)

Epidemiology of mental health comorbidity in psoriasis
by: J. J. Wu, et al.
Published: (2018-07-01)

Comorbidity Burden and Treatment Patterns of Psoriasis in Vietnam: Real-World Data from the EXPAND Study
by: Hao Trong Nguyen, et al.
Published: (2023-11-01)

COMORBIDITIES IN PSORIATIC ARTHRITIS AND PSORIASIS: CONSIDERATIONS FOR THE CLINICIAN
by: Lucia Dutca, et al.
Published: (2023-12-01)

Psoriasis comorbid with atherosclerosis meets in lipid metabolism
by: Liuping Chen, et al.
Published: (2023-12-01)

A META-ANALYSIS OF OBSERVATIVE STUDIES REGARDING METABOLIC SYNDROME AS A COMORBIDITY OF PSORIASIS
by: Ana Maria Alexandra Stănescu, et al.
Published: (2019-03-01)

Advancements in the Study of Biologic Agents in Comorbidities of Psoriasis: A Literature Review
by: Wang Y, et al.
Published: (2023-12-01)

Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis)
by: Luigi Gargiulo, et al.
Published: (2023-08-01)

Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: pooled analysis of 4 phase 3 clinical trials
by: Alice B. Gottlieb, et al.
Published: (2022-04-01)

Psoriasis and psychiatric disorders
by: H. Ghabi, et al.
Published: (2021-04-01)

Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review
by: Andrea Marani, et al.
Published: (2022-06-01)

Body Composition, Cardiometabolic Risk Factors and Comorbidities in Psoriasis and the Effect of HLA-C*06:02 Status: The HUNT Study, Norway
by: Åshild Øksnevad Solvin, et al.
Published: (2023-05-01)

Research progress of LncRNA NEAT1 in psoriasis and its comorbidities
by: Zhiming TANG, et al.
Published: (2023-02-01)

Successful therapy of plaque-type psoriasis with secukinumab in patients with multiple comorbidities treated with previous biologic therapies
by: Claudia Lasagni, et al.
Published: (2018-12-01)

Killing all the birds with one drug – is oral roflumilast a novel treatment option for psoriasis?
by: Mette Gyldenløve, et al.
Published: (2022-08-01)

Apremilast in psoriasis patients with serious comorbidities: a case series and systematic review of literature
by: Aikaterini Tsentemeidou, et al.
Published: (2022-10-01)

The Role of Osteopontin in Psoriasis—A Scoping Review
by: Agnieszka Kimak, et al.
Published: (2024-01-01)

COMORBID CONDITIONS IN PSORIASIS
by: А. В. Брынина, et al.
Published: (2023-03-01)

Psoriasis: a personalized approach to therapy. The preferred choice of systemic agents considering comorbid pathologies
by: N. N. Potekaev, et al.
Published: (2020-10-01)

Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study—IL PSO (Italian landscape psoriasis)
by: Luigi Gargiulo, et al.
Published: (2023-07-01)

Chronic Plaque Psoriasis in Poland: Disease Severity, Prevalence of Comorbidities, and Quality of Life
by: Dorota Purzycka-Bohdan, et al.
Published: (2022-02-01)

The risk of organ-based comorbidities in psoriasis: a systematic review and meta-analysis
by: Xuemei Tang, et al.
Published: (2022-09-01)

Management of moderate to severe psoriasis in patients with metabolic comorbidities
by: Paolo eGisondi, et al.
Published: (2015-01-01)

Psoriasis: Not just skin deep
by: Malcolm Pinto, et al.
Published: (2015-01-01)

Pediatric patients with psoriasis and psychiatric disorders: premorbidity and comorbidity in a case-control study
by: Tayfun Kara, et al.
Published: (2019-02-01)

Exploration of the underlying comorbidity mechanism in psoriasis and periodontitis: a bioinformatics analysis
by: Hao Lei, et al.
Published: (2023-02-01)

Knowledge Mapping and Research Hotspots of Comorbidities in Psoriasis: A Bibliometric Analysis from 2004 to 2022
by: Shan Huang, et al.
Published: (2023-02-01)

Profile of patients receiving medical care at a reference, support, and treatment center for psoriasis patients at a university hospital
by: Túlio Germano Machado Cordeiro Júnior, et al.
Published: (2016-10-01)

Ocular Manifestations in Psoriasis Screening (OcMaPS) Questionnaire: A Useful Tool to Reveal Misdiagnosed Ocular Involvement in Psoriasis
by: Angelo Ruggiero, et al.
Published: (2021-03-01)

Psoriasis comorbidity management in the COVID era: a pressing challenge
by: Yang Song, et al.
Published: (2023-11-01)

The link between psoriasis and other diseases based on epidemiological and genetic analyses
by: Zygmunt Adamski, et al.
Published: (2023-09-01)

A Propensity Score-Matched Study on the Changes of TB Status and TB-IGRA Values in Patients with Psoriasis with Latent TB Receiving Secukinumab
by: Yue Xiao, et al.
Published: (2023-08-01)

Long-term use of fumaric acid esters for the treatment of psoriasis in daily practice
by: Christian Termeer, et al.
Published: (2021-08-01)